Ms Heng is also honoured to have been invited as speaker to various meetings and conferences including Roche Oculus meeting 2025, Bayer OCTANE meeting, Bayer A-Z of Retina Diseases, BUPA GP meeting, Roche Morocco, ‘Morocco Ophthalmology Emerging Leaders Program’, etc.
She is also chairperson for several Preceptorship programs.
She was Chair for the Arabic Preceptorship program in 2025 and Saudi Preceptorship program 2026 where we welcomed Ophthalmologists from other countries for 2 days of teaching at Moorfields Eye Hospital. This program is jointly organised with ESASO foundation and Moorfields Eye Hospital.
Ms Heng is also chair of the Moorfields Retina Laser Course which has been running over the last 3 years and has chaired various meetings including the Pan London Retina Fellows Meeting over the last 4 years.
Ms Heng was also honoured to have been part of delegate of Moorfields Eye Hospital invited by the Egyptian Health Authorities and Roche Egypt for a visit to Port Said Eye Hospital to advise on retina screening and building a centre of excellence for retina diseases.
Ms Heng is chief investigator for several clinical studies
SIBA study- looking at inequality within the medical retina digital clinics
Wet AMD Burden Study- looking at treatment burden and efficacy across different types of antivegf to patients, carers and service providers.
She was also involved as principal and subinvestigator of numerous pivotal clinical trials including the 2RT RETILASE study and OZLASE study(one of the first studies to evaluate use of ozurdex steroid implant in diabetic macular oedema in the UK) in the course of her career.
She has made in excess of 50 international presentations across the world.
Ms Heng’s PhD was on preventative therapy in Age Related Macular Degeneration- ‘The use of the nanosecond laser technology to retard the onset of age related macular degeneration’. Her PhD is often used as a teaching guide for the pathophysiology of lasers.
Ms. Heng was involved in numerous phase II/III clinical trials for medical retinal diseases (AMD and diabetic retinopathy), including the OZLASE, TENAYA, and RHINE studies. These studies investigated new treatments or protocols for diabetic macular oedema and AMD.
Accepted for Publication: British Journal for Publication
Real-world early outcomes of intravitreal faricimab 6mg and aflibercept 2mg injection in diabetic macular oedema
Ms. Heng leads the Retina Digital Clinic at Moorfields Eye Hospital, where more than a thousand patients are reviewed on a weekly basis. She is keen on improving clinical governance within the sphere of digital medicine and benchmarking standards and quality within digital clinics.
She is also the Chief Investigator of a health inequality study to determine the barriers to, and acceptability of, digital clinics.
BJO April 2026
A Comparison of Ultra-Widefield Imaging Quality Obtained with Zeiss Clarus and Optos for Virtual Medical Retina Services
May 2025- Journal of Clinical Medicine
Effect of ethnicity and other sociodemographic factors on attendance at ophthalmology appointments following referral from a Diabetic Eye Screening Programme: a retrospective cohort study.Jan 2025- British Medical Journal Open
Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP) in a Man with Prostate AdenocarcinomaJournal of French Ophthalmology
Efficacy and Safety outcomes of a novel model to assess new medical retina referrals in a high- volume medical retina virtual clinicEye 38, 168-172 (2024)pages168–172 (2024volume 38, pages168–172 (2024 volume 38, pages168–172 (2024
Heng LZ, R. Hamilton
